120 related articles for article (PubMed ID: 35328282)
1. Analytic and Clinical Validation of a Pan-Cancer NGS Liquid Biopsy Test for the Detection of Copy Number Amplifications, Fusions and Exon Skipping Variants.
Audetat A; Tschida C; Kreston S; Stephen A; D'Alessio B; Bondy M; Jackson L; Mellert H; Givens N; Sathyanarayana UG; Pestano GA
Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328282
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
Bustamante Alvarez JG; Janse S; Owen DH; Kiourtsis S; Bertino EM; He K; Carbone DP; Otterson GA
Clin Lung Cancer; 2021 Jul; 22(4):e519-e527. PubMed ID: 33414052
[TBL] [Abstract][Full Text] [Related]
3. Incidence and PD-L1 Expression of
Xu Z; Li H; Dong Y; Cheng P; Luo F; Fu S; Gao M; Kong L; Che N
Onco Targets Ther; 2020; 13():6245-6253. PubMed ID: 32669854
[TBL] [Abstract][Full Text] [Related]
4. Clinical Utility Validation of an Automated Ultrarapid Gene Fusion Assay for NSCLC.
Buglioni A; Caffes PL; Hessler MG; Mansfield AS; Lo YC
JTO Clin Res Rep; 2022 Dec; 3(12):100434. PubMed ID: 36536899
[TBL] [Abstract][Full Text] [Related]
5. Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in NSCLC.
Yi H; Youk J; Lim Y; Roh H; Roh D; Kyung D; Kim HP; Bang D; Keam B; Kim TM; Kim M; Kim DW; Kim TY
Cancer Res Treat; 2024 Jan; ():. PubMed ID: 38186238
[TBL] [Abstract][Full Text] [Related]
6. Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing.
Cohen D; Hondelink LM; Solleveld-Westerink N; Uljee SM; Ruano D; Cleton-Jansen AM; von der Thüsen JH; Ramai SRS; Postmus PE; Graadt van Roggen JF; Hoppe BPC; Clahsen PC; Maas KW; Ahsmann EJM; Ten Heuvel A; Smedts F; van Rossem RN; van Wezel T
J Thorac Oncol; 2020 Jun; 15(6):1000-1014. PubMed ID: 32014610
[TBL] [Abstract][Full Text] [Related]
7. Clinical Utility of Cell-Free DNA for the Detection of
McCoach CE; Blakely CM; Banks KC; Levy B; Chue BM; Raymond VM; Le AT; Lee CE; Diaz J; Waqar SN; Purcell WT; Aisner DL; Davies KD; Lanman RB; Shaw AT; Doebele RC
Clin Cancer Res; 2018 Jun; 24(12):2758-2770. PubMed ID: 29599410
[No Abstract] [Full Text] [Related]
8. Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer.
Guibert N; Hu Y; Feeney N; Kuang Y; Plagnol V; Jones G; Howarth K; Beeler JF; Paweletz CP; Oxnard GR
Ann Oncol; 2018 Apr; 29(4):1049-1055. PubMed ID: 29325035
[TBL] [Abstract][Full Text] [Related]
9. Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation.
Fernandes MGO; Jacob M; Martins N; Moura CS; Guimarães S; Reis JP; Justino A; Pina MJ; Cirnes L; Sousa C; Pinto J; Marques JA; Machado JC; Hespanhol V; Costa JL
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31443496
[TBL] [Abstract][Full Text] [Related]
10. Resistance Mechanisms to Targeted Therapies in
McCoach CE; Le AT; Gowan K; Jones K; Schubert L; Doak A; Estrada-Bernal A; Davies KD; Merrick DT; Bunn PA; Purcell WT; Dziadziuszko R; Varella-Garcia M; Aisner DL; Camidge DR; Doebele RC
Clin Cancer Res; 2018 Jul; 24(14):3334-3347. PubMed ID: 29636358
[No Abstract] [Full Text] [Related]
11. Identifying a wide range of actionable variants using capture-based ultra-deep targeted sequencing in treatment-naive patients with primary lung adenocarcinoma.
Chen L; Chen M; Lin J; Chen X; Yu X; Chen Z; Jin L
Int J Clin Exp Pathol; 2020; 13(3):525-535. PubMed ID: 32269691
[TBL] [Abstract][Full Text] [Related]
12. Frequency of
Champagnac A; Bringuier PP; Barritault M; Isaac S; Watkin E; Forest F; Maury JM; Girard N; Brevet M
J Thorac Dis; 2020 May; 12(5):2172-2178. PubMed ID: 32642122
[TBL] [Abstract][Full Text] [Related]
13. MET Exon 14 Skipping in Non-Small Cell Lung Cancer.
Heist RS; Shim HS; Gingipally S; Mino-Kenudson M; Le L; Gainor JF; Zheng Z; Aryee M; Xia J; Jia P; Jin H; Zhao Z; Pao W; Engelman JA; Iafrate AJ
Oncologist; 2016 Apr; 21(4):481-6. PubMed ID: 27022036
[TBL] [Abstract][Full Text] [Related]
14. Validation of quantitative PCR-based assays for detection of gene copy number aberrations in formalin-fixed, paraffin embedded solid tumor samples.
Mehrotra M; Luthra R; Abraham R; Mishra BM; Virani S; Chen H; Routbort MJ; Patel KP; Medeiros LJ; Singh RR
Cancer Genet; 2017 Apr; 212-213():24-31. PubMed ID: 28449808
[TBL] [Abstract][Full Text] [Related]
15. Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC.
Hofman V; Heeke S; Bontoux C; Chalabreysse L; Barritault M; Bringuier PP; Fenouil T; Benzerdjeb N; Begueret H; Merlio JP; Caumont C; Piton N; Sabourin JC; Evrard S; Syrykh C; Vigier A; Brousset P; Mazieres J; Long-Mira E; Benzaquen J; Boutros J; Allegra M; Tanga V; Lespinet-Fabre V; Salah M; Bonnetaud C; Bordone O; Lassalle S; Marquette CH; Ilié M; Hofman P
JTO Clin Res Rep; 2023 Feb; 4(2):100457. PubMed ID: 36718140
[TBL] [Abstract][Full Text] [Related]
16. An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients.
Wei J; Rybczynska AA; Meng P; Terpstra M; Saber A; Sietzema J; Timens W; Schuuring E; Hiltermann TJN; Groen HJM; van der Wekken AJ; van den Berg A; Kok K
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33019710
[TBL] [Abstract][Full Text] [Related]
17. Concomitance of a novel RMDN2-ALK fusion and an EML4-ALK fusion in a lung adenocarcinoma.
Jiang L; Chen S; Stinnett V; Haley L; Morsberger L; Shane A; Hardy M; Smith K; Gocke CD; Lin MT; Zou YS
Cancer Genet; 2021 Nov; 258-259():18-22. PubMed ID: 34233240
[TBL] [Abstract][Full Text] [Related]
18. DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer.
Davies KD; Lomboy A; Lawrence CA; Yourshaw M; Bocsi GT; Camidge DR; Aisner DL
J Thorac Oncol; 2019 Apr; 14(4):737-741. PubMed ID: 30639620
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA.
Supplee JG; Milan MSD; Lim LP; Potts KT; Sholl LM; Oxnard GR; Paweletz CP
Lung Cancer; 2019 Aug; 134():96-99. PubMed ID: 31320002
[TBL] [Abstract][Full Text] [Related]
20. Genomic Profiling Reveals Synchronous Bilateral Lung Adenocarcinomas With Distinct Driver Alterations of
Tan B; Jiang X; Wang R; Tang C; Liu S; Wu X; Xia L; Yu X; Yang Z
Front Oncol; 2019; 9():1319. PubMed ID: 31828041
[No Abstract] [Full Text] [Related]
[Next] [New Search]
